Qinghai Spring Medicinal Resources Technology Co., Ltd.

Equities

600381

CNE0000017W0

Pharmaceuticals

End-of-day quote Shanghai S.E. 23:00:00 27/06/2024 BST 5-day change 1st Jan Change
2.01 CNY +3.08% Intraday chart for Qinghai Spring Medicinal Resources Technology Co., Ltd. -6.51% -74.00%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Qinghai Spring Medicinal Resources Technology's Unit Fined Over Misleading Advertising MT
Qinghai Spring Medicinal Resources Technology Co., Ltd.(SHSE:600381) dropped from Shanghai Stock Exchange Composite Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(SHSE:600381) dropped from Shanghai Stock Exchange A Share Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) dropped from S&P Global BMI Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. authorizes a Buyback Plan. CI
Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) added to S&P Global BMI Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Beijing Life Capital Management Co., Ltd. completed the acquisition of a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. CI
Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million. CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Chart Qinghai Spring Medicinal Resources Technology Co., Ltd.
More charts
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600381 Stock
  4. News Qinghai Spring Medicinal Resources Technology Co., Ltd.
  5. Qinghai Spring Medicinal Resources Technology's Unit Fined Over Misleading Advertising